Takeda

Pharma

Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia

Merck and Kelun's sac-TMT reported three positive phase 3s. Experts talk useful tools in China dealmaking. Takeda was hit with a pay-for-delay verdict.

Angus Liu May 22, 2026 8:53am

Jury awards $885M in Takeda pay-for-delay antitrust case

May 19, 2026 8:39am

BMS-Hengrui, Takeda layoffs, Daiichi—Fierce Pharma Asia

May 15, 2026 8:30am

Takeda's $1.3B savings drive to impact 4,500 roles in '26

May 13, 2026 11:41am

Summit, UCB-Candid, J&J—Fierce Pharma Asia

May 8, 2026 8:30am

Sun-Organon, Astellas, BeOne—Fierce Pharma Asia

May 1, 2026 8:43am